News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Taylor Daphne
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| Taylor Daphne (SVP, CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Exercised 6,945 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Taylor Daphne (SVP, CFO) has filed a Form 4 on Aptevo Therapeutics Inc.|
Txns:
| Granted 11,000 options to buy
@ $2.15, valued at
$23.7k
Granted 11,000 restricted stock units
@ $0
Exercised 1,583 restricted stock units
@ $0 |
|
| 03/07/2023 |
3
| Taylor Daphne (SVP, CFO) has filed a Form 3 on Aptevo Therapeutics Inc. |
| 05/06/2015 |
4
| Taylor Daphne L (CFO) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Granted 174,510 options to buy
@ $2.06, valued at
$359.5k
|
|
| 02/17/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/23/2011 |
4
| Taylor Daphne L (CFO) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Granted 500,000 options to buy
@ $0.063, valued at
$31.5k
|
|
| 08/23/2011 |
3
| Taylor Daphne L (CFO) has filed a Form 3 on BIOLIFE SOLUTIONS INC |
| 03/10/2009 |
4
| Taylor Daphne L (VP, Chief Accounting Officer) has filed a Form 4 on Cardiac Science CORP |
|
|